These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 12918099)

  • 41. Biological effects of irradiating hepatocellular carcinoma cells by internal exposure with 125I-labeled 5-iodo-2'-deoxyuridine-chitosan drug loading nanoparticles.
    Yang C; Zhu R; Wan J; Jiang B; Zhou D; Song M; Liu F
    Cancer Biother Radiopharm; 2014 Nov; 29(9):395-402. PubMed ID: 25379613
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Selective targeting by preS1 domain of hepatitis B surface antigen conjugated with phosphorylcholine-based amphiphilic block copolymer micelles as a biocompatible, drug delivery carrier for treatment of human hepatocellular carcinoma with paclitaxel.
    Miyata R; Ueda M; Jinno H; Konno T; Ishihara K; Ando N; Kitagawa Y
    Int J Cancer; 2009 May; 124(10):2460-7. PubMed ID: 19173297
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cation-induced restoration of insulin action in insulin-desensitized HTC cells.
    Williams PF; Zilkens RR; Caterson ID; Cooney GJ
    Endocrinology; 1991 Jul; 129(1):249-55. PubMed ID: 1711461
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Thymidine kinase activity of ocular herpes simplex isolates resistant to IUDR therapy.
    Funderburgh ML; Funderburgh JL; Chandler JW
    Invest Ophthalmol Vis Sci; 1986 Oct; 27(10):1546-8. PubMed ID: 3759371
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Iododeoxyuridine uptake and retention as a measure of tumor growth.
    Tjuvajev J; Muraki A; Ginos J; Berk J; Koutcher J; Ballon D; Beattie B; Finn R; Dahighian F; Blasberg R
    J Nucl Med; 1993 Jul; 34(7):1152-62. PubMed ID: 8315494
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Magnetic polycarbonate microspheres for tumor-targeted delivery of tumor necrosis factor.
    Hu B; Du HJ; Yan GP; Zhuo RX; Wu Y; Fan CL
    Drug Deliv; 2014 May; 21(3):204-12. PubMed ID: 24117028
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of insulin on an insulin receptor of PLC/PRF/5 human hepatoma cell line.
    Testa I; Clementi M; Festa A; Bagnarelli P; Brugia M; de Martinis C
    Dev Biol Stand; 1985; 60():81-91. PubMed ID: 2995179
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Expression of growth hormone receptor in hepatocellular carcinoma and its significance].
    Liu JP; Wang HT; Ou QJ; Lu YT; Lu HP; Gao JH; Chu ZH; Zhao HY
    Ai Zheng; 2003 Mar; 22(3):298-301. PubMed ID: 12654191
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Glycyrrhetinic Acid-Mediated Polymeric Drug Delivery Targeting the Acidic Microenvironment of Hepatocellular Carcinoma.
    Zhang J; Zhang M; Ji J; Fang X; Pan X; Wang Y; Wu C; Chen M
    Pharm Res; 2015 Oct; 32(10):3376-90. PubMed ID: 26148773
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Successful targeted therapies for hepatocellular carcinoma: are we really getting there?
    Zhu AX
    Expert Rev Anticancer Ther; 2008 Apr; 8(4):499-505. PubMed ID: 18402516
    [No Abstract]   [Full Text] [Related]  

  • 51. Enhancement of erythropoietin production by selective adenosine A2 receptor agonists in response to hypoxia.
    Ohigashi T; Nakashima J; Aggarwal S; Brookins J; Agrawal K; Fisher JW
    J Lab Clin Med; 1995 Sep; 126(3):299-306. PubMed ID: 7665979
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Synergistic combination effect of cidofovir and idoxuridine on vaccinia virus replication.
    Remichkova M; Petrov N; Galabov AS
    Antivir Chem Chemother; 2006; 17(2):53-8. PubMed ID: 17042327
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Signaling pathway and molecular-targeted therapy for hepatocellular carcinoma.
    Kudo M
    Dig Dis; 2011; 29(3):289-302. PubMed ID: 21829020
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tumor targeting by intra-arterial infusion of 5-[123I]iodo-2'-deoxyuridine in patients with liver metastases from colorectal cancer.
    Mariani G; Di Sacco S; Volterrani D; Di Luca L; Buralli S; Di Stefano R; Baranowska-Kortylewicz J; Bonora D; Matteucci F; Ricci S; Bellina CR; Falcone A; Salvadori PA; Mosca F; Adelstein SJ; Kassis AI
    J Nucl Med; 1996 Apr; 37(4 Suppl):22S-25S. PubMed ID: 8676199
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A supramolecular nanoparticle system based on β-cyclodextrin-conjugated poly-l-lysine and hyaluronic acid for co-delivery of gene and chemotherapy agent targeting hepatocellular carcinoma.
    Xiong Q; Cui M; Bai Y; Liu Y; Liu D; Song T
    Colloids Surf B Biointerfaces; 2017 Jul; 155():93-103. PubMed ID: 28411478
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Iodo-2'-deoxyuridine (IUdR) and 125IUdR loaded biodegradable microspheres for controlled delivery to the brain.
    Reza MS; Whateley TL
    J Microencapsul; 1998; 15(6):789-801. PubMed ID: 9818956
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Leptin signaling molecular actions and drug target in hepatocellular carcinoma.
    Jiang N; Sun R; Sun Q
    Drug Des Devel Ther; 2014; 8():2295-302. PubMed ID: 25484575
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Radiolabeled nucleoside analogs in cancer diagnosis and therapy.
    Kassis AI; Adelstein SJ; Mariani G
    Q J Nucl Med; 1996 Sep; 40(3):301-19. PubMed ID: 8961807
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Experimental study of transferrin receptor molecular imaging in human hepatocellular carcinoma transplanted in nude mice].
    Wu ZJ; Zhang YX
    Zhonghua Zhong Liu Za Zhi; 2006 Feb; 28(2):96-8. PubMed ID: 16750010
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Taurine binding to the purified insulin receptor.
    Maturo J; Kulakowski EC
    Biochem Pharmacol; 1988 Oct; 37(19):3755-60. PubMed ID: 3052459
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.